Bacillus Coagulans for Immune Function

Research suggests that Bacillus coagulans may support various aspects of immune function, with studies across multiple populations and species reporting improvements in immune markers such as natural killer cell activity, immunoglobulin levels (IgA, IgG, IgM), and anti-inflammatory cytokines like IL-10. The evidence base includes a small number of randomized controlled trials in humans — notably one in older adults showing increased Faecalibacterium prausnitzii and modest IL-10 responses, and another in older adults demonstrating meaningfully increased NK cell activity and salivary IgA — alongside a larger body of animal studies in piglets, poultry, fish, and cattle that consistently report reduced inflammation and enhanced immune protein levels. A pediatric RCT also found that Bacillus coagulans combined with infection control measures improved clinical and immune outcomes in hospitalized children, though the single-center design and small sample size limit how broadly those findings can be applied. Overall the research is directionally supportive but methodologically limited — most human studies are small, short-term, or preliminary in nature, some findings fell short of statistical significance, and the substantial reliance on animal models means that firm conclusions about immune benefits in humans should await larger, more rigorously designed trials.